ALDEFLUOR activity, ALDH isoforms, and their clinical significance in cancers

References

• Black WJ, Stagos D, Marchitti SA, Nebert DW, Tipton KF, Bairoch A, Vasiliou V. Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature. Pharmacogenet Genom. 2009;19(11):893–902.
   PubMed Web of Science ®Google Scholar
• Ma I, Allan AL. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev Rep. 2011;7(2):292–306.
   PubMed Web of Science ®Google Scholar
• Marchitti SA, Brocker C, Stagos D, Vasiliou V. Non-p450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol. 2008;4(6):697–720.
   PubMed Web of Science ®Google Scholar
• Jackson B, Brocker C, Thompson DC, Black W, Vasiliou K, Nebert DW, Vasiliou V. Update on the aldehyde dehydrogenase gene (aldh) superfamily. Hum Genomics. 2011;5(4):283–303.
   PubMedGoogle Scholar
• Vasiliou V, Pappa A, Estey T. Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism. Drug Metab Rev. 2004;36(2):279–299.
   PubMed Web of Science ®Google Scholar
• Dockham PA, Lee MO, Sladek NE. Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde. Biochem Pharmacol. 1992;43(11):2453–2469.
   PubMed Web of Science ®Google Scholar
• el Akawi Z, Napoli JL. Rat liver cytosolic retinal dehydrogenase: comparison of 13-cis-, 9-cis-, and all-trans-retinal as substrates and effects of cellular retinoid-binding proteins and retinoic acid on activity. Biochemistry. 1994;33(7):1938–1943.
   PubMed Web of Science ®Google Scholar
• Grun F, Hirose Y, Kawauchi S, Ogura T, Umesono K. Aldehyde dehydrogenase 6, a cytosolic retinaldehyde dehydrogenase prominently expressed in sensory neuroepithelia during development. J Biol Chem. 2000;275(52):41210–41218.
   PubMed Web of Science ®Google Scholar
• Wang X, Penzes P, Napoli JL. Cloning of a cdna encoding an aldehyde dehydrogenase and its expression in escherichia coli. Recognition of retinal as substrate. J Biol Chem. 1996;271(27):16288–16293.
   PubMed Web of Science ®Google Scholar
• Lin M, Napoli JL. Cdna cloning and expression of a human aldehyde dehydrogenase (aldh) active with 9-cis-retinal and identification of a rat ortholog, aldh12. J Biol Chem. 2000;275(51):40106–40112.
   PubMed Web of Science ®Google Scholar
• Lin M, Zhang M, Abraham M, Smith SM, Napoli JL. Mouse retinal dehydrogenase 4 (raldh4), molecular cloning, cellular expression, and activity in 9-cis-retinoic acid biosynthesis in intact cells. J Biol Chem. 2003;278(11):9856–9861.
   PubMed Web of Science ®Google Scholar
• Sophos NA, Pappa A, Ziegler TL, Vasiliou V. Aldehyde dehydrogenase gene superfamily: the 2000 update. Chem Biol Interact. 2001;130–132(1–3):323–337.
   PubMed Web of Science ®Google Scholar
• Keysar SB, Jimeno A. More than markers: biological significance of cancer stem cell-defining molecules. Mol Cancer Ther. 2010;9(9):2450–2457.
   PubMed Web of Science ®Google Scholar
• Visus C, Ito D, Amoscato A, Maciejewska-Franczak M, Abdelsalem A, Dhir R, Shin DM, Donnenberg VS, Whiteside TL, DeLeo AB. Identification of human aldehyde dehydrogenase 1 family member a1 as a novel cd8+ t-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res. 2007;67(21):10538–10545.
   PubMed Web of Science ®Google Scholar
• Yoon KA, Nakamura Y, Arakawa H. Identification of aldh4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet. 2004;49(3):134–140.
   PubMed Web of Science ®Google Scholar
• Clark DW, Palle K. Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets. Ann Transl Med. 2016;4(24):518–518.
   PubMed Web of Science ®Google Scholar
• Moreb JS, Ucar D, Han S, Amory JK, Goldstein AS, Ostmark B, Chang LJ. The enzymatic activity of human aldehyde dehydrogenases 1a2 and 2 (aldh1a2 and aldh2) is detected by aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. Chem Biol Interact. 2012;195(1):52–60.
   PubMed Web of Science ®Google Scholar
• Giorgianni F, Bridson PK, Sorrentino BP, Pohl J, Blakley RL. Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3. Biochem Pharmacol. 2000;60(3):325–338.
   PubMed Web of Science ®Google Scholar
• Magni M, Shammah S, Schiro R, Mellado W, Dalla-Favera R, Gianni AM. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood. 1996;87(3):1097–1103.
   PubMed Web of Science ®Google Scholar
• Storms RW, Trujillo AP, Springer JB, Shah L, Colvin OM, Ludeman SM, Smith C. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA. 1999;96(16):9118–9123.
   PubMed Web of Science ®Google Scholar
• Kastan MB, Schlaffer E, Russo JE, Colvin OM, Civin CI, Hilton J. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood. 1990;75(10):1947–1950.
   PubMed Web of Science ®Google Scholar
• Estes BT, Wu AW, Storms RW, Guilak F. Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adipose-derived adult stem cells. J Cell Physiol. 2006;209(3):987–995.
   PubMed Web of Science ®Google Scholar
• Jean E, Laoudj-Chenivesse D, Notarnicola C, Rouger K, Serratrice N, Bonnieu A, Gay S, Bacou F, Duret C, Carnac G. Aldehyde dehydrogenase activity promotes survival of human muscle precursor cells. J Cell Mol Med. 2011;15(1):119–133.
   PubMed Web of Science ®Google Scholar
• Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, et al. Aldh1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1(5):555–567.
   PubMed Web of Science ®Google Scholar
• Dalley AJ, AbdulMajeed AA, Upton Z, Farah CS. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of cd44 and p75 ntr in malignancy. J Oral Pathol Med. 2013;42(1):37–46.
   PubMed Web of Science ®Google Scholar
• Lohberger B, Rinner B, Stuendl N, Absenger M, Liegl-Atzwanger B, Walzer SM, Windhager R, Leithner A. Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma. PLoS One. 2012;7(8):e43664.
   PubMed Web of Science ®Google Scholar
• Minato T, Yamamoto Y, Seike J, Yoshida T, Yamai H, Takechi H, Yuasa Y, Furukita Y, Goto M, Bando Y, et al. Aldehyde dehydrogenase 1 expression is associated with poor prognosis in patients with esophageal squamous cell carcinoma. Ann Surg Oncol. 2013;20(1):209–217.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhe H, Gao P, Zhang N, Li G, Qin J. Cancer stem cell marker aldh1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern china. Dis Esophagus. 2012;25(6):560–565.
   PubMed Web of Science ®Google Scholar
• Rassouli FB, Matin MM, Saeinasab M. Cancer stem cells in human digestive tract malignancies. Tumour Biol. 2016;37(1):7–21.
   PubMedGoogle Scholar
• Katsuno Y, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K. Coordinated expression of reg4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by tgf-beta. J Pathol. 2012;228(3):391–404.
   PubMed Web of Science ®Google Scholar
• Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y, Uraoka N, Anami K, Sentani K, Oue N, Yasui W. Expression of cancer stem cell markers aldh1, cd44 and cd133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int. 2012;62(2):112–119.
   PubMed Web of Science ®Google Scholar
• Carpentino JE, Hynes MJ, Appelman HD, Zheng T, Steindler DA, Scott EW, Huang EH. Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer. Cancer Res. 2009;69(20):8208–8215.
   PubMed Web of Science ®Google Scholar
• Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS, Boman BM. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (sc) and tracks sc overpopulation during colon tumorigenesis. Cancer Res. 2009;69(8):3382–3389.
   PubMed Web of Science ®Google Scholar
• Kozovska Z, Patsalias A, Bajzik V, Durinikova E, Demkova L, Jargasova S, Smolkova B, Plava J, Kucerova L, Matuskova M. Aldh1a inhibition sensitizes colon cancer cells to chemotherapy. BMC Cancer. 2018;18(1):656.
   PubMedGoogle Scholar
• Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun. 2009;385(3):307–313.
   PubMed Web of Science ®Google Scholar
• Kurashige T, Shimamura M, Yasui K, Mitsutake N, Matsuse M, Nakashima M, Minami S, Eguchi S, Nagayama Y. Studies on expression of aldehyde dehydrogenase in normal and cancerous tissues of thyroids. Horm Metab Res. 2015;47(3):194–199.
   PubMed Web of Science ®Google Scholar
• Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res. 2009;7(3):330–338.
   PubMed Web of Science ®Google Scholar
• Li X, Wan L, Geng J, Wu CL, Bai X. Aldehyde dehydrogenase 1a1 possesses stem-like properties and predicts lung cancer patient outcome. J Thorac Oncol. 2012;7(8):1235–1245.
   PubMed Web of Science ®Google Scholar
• Moreb JS, Baker HV, Chang LJ, Amaya M, Lopez MC, Ostmark B, Chou W. Aldh isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells. Mol Cancer. 2008;7:87.
   PubMed Web of Science ®Google Scholar
• Chen MH, Weng JJ, Cheng CT, Wu RC, Huang SC, Wu CE, Chung YH, Liu CY, Chang MH, Chen MH, et al. Aldh1a3, the major aldehyde dehydrogenase isoform in human cholangiocarcinoma cells, affects prognosis and gemcitabine resistance in cholangiocarcinoma patients. Clin Cancer Res. 2016;22(16):4225–4235.
   PubMed Web of Science ®Google Scholar
• Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, Guan XY. Aldehyde dehydrogenase discriminates the cd133 liver cancer stem cell populations. Mol Cancer Res. 2008;6(7):1146–1153.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Tomita H, Hisamatsu K, Nakashima T, Hatano Y, Sasaki Y, Osada S, Tanaka T, Miyazaki T, Yoshida K, et al. Aldh1a1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma. Oncotarget. 2015;6(28):24722–24732.
   PubMedGoogle Scholar
• Rasheed Z, Wang Q, Matsui W. Isolation of stem cells from human pancreatic cancer xenografts. J Vis Exp. 2010;43:2169.
   Google Scholar
• Rasheed ZA, Yang J, Wang Q, Kowalski J, Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X, et al. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst. 2010;102(5):340–351.
   PubMedGoogle Scholar
• Ishizawa K, Rasheed ZA, Karisch R, Wang Q, Kowalski J, Susky E, Pereira K, Karamboulas C, Moghal N, Rajeshkumar NV, et al. Tumor-initiating cells are rare in many human tumors. Cell Stem Cell. 2010;7(3):279–282.
   PubMed Web of Science ®Google Scholar
• Honoki K, Fujii H, Kubo A, Kido A, Mori T, Tanaka Y, Tsujiuchi T. Possible involvement of stem-like populations with elevated aldh1 in sarcomas for chemotherapeutic drug resistance. Oncol Rep. 2010;24(2):501–505.
   PubMed Web of Science ®Google Scholar
• Martins-Neves SR, Corver WE, Paiva-Oliveira DI, van den Akker BE, Briaire-de-Bruijn IH, Bovee JV, Gomes CM, Cleton-Jansen AM. Osteosarcoma stem cells have active Wnt/β-catenin and overexpress SOX2 and KLF4. J Cell Physiol. 2016;231(4):876–886.
   PubMed Web of Science ®Google Scholar
• Martins-Neves SR, Paiva-Oliveira DI, Wijers-Koster PM, Abrunhosa AJ, Fontes-Ribeiro C, Bovee JV, Cleton-Jansen AM, Gomes CM. Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/β-catenin signaling. Cancer Lett. 2016;370(2):286–295.
   PubMed Web of Science ®Google Scholar
• Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z, Stass SA, Jiang F. Aldh1a1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome. Lab Invest. 2010;90(2):234–244.
   PubMed Web of Science ®Google Scholar
• van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Pelger RC, van der Pluijm G. The aldehyde dehydrogenase enzyme 7a1 is functionally involved in prostate cancer bone metastasis. Clin Exp Metastasis. 2011;28(7):615–625.
   PubMed Web of Science ®Google Scholar
• Falso MJ, Buchholz BA, White RW. Stem-like cells in bladder cancer cell lines with differential sensitivity to cisplatin. Anticancer Res. 2012;32(3):733–738.
   PubMed Web of Science ®Google Scholar
• Ferreira-Teixeira M, Parada B, Rodrigues-Santos P, Alves V, Ramalho JS, Caramelo F, Sousa V, Reis F, Gomes CM. Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors. Oncotarget. 2015;6(34):36185–36201.
   PubMedGoogle Scholar
• Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu Z, Stass SA, Jiang F. Aldehyde dehydrogenase 1 a1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2010;19(2):327–337.
   PubMed Web of Science ®Google Scholar
• Rasper M, Schafer A, Piontek G, Teufel J, Brockhoff G, Ringel F, Heindl S, Zimmer C, Schlegel J. Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro Oncol. 2010;12(10):1024–1033.
   PubMed Web of Science ®Google Scholar
• Boonyaratanakornkit JB, Yue L, Strachan LR, Scalapino KJ, LeBoit PE, Lu Y, Leong SP, Smith JE, Ghadially R. Selection of tumorigenic melanoma cells using aldh. J Invest Dermatol. 2010;130(12):2799–2808.
   PubMed Web of Science ®Google Scholar
• Chang B, Liu G, Xue F, Rosen DG, Xiao L, Wang X, Liu J. Aldh1 expression correlates with favorable prognosis in ovarian cancers. Mod Pathol. 2009;22(6):817–823.
   PubMed Web of Science ®Google Scholar
• Januchowski R, Wojtowicz K, Sterzyſska K, Sosiſska P, Andrzejewska M, Zawierucha P, Nowicki M, Zabel M. Inhibition of aldh1a1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines. Int J Biochem Cell Biol. 2016;78:248–259.
   PubMed Web of Science ®Google Scholar
• Huddle BC, Grimley E, Buchman CD, Chtcherbinine M, Debnath B, Mehta P, Yang K, Morgan CA, Li S, Felton J, et al. Structure-based optimization of a novel class of aldehyde dehydrogenase 1a (aldh1a) subfamily-selective inhibitors as potential adjuncts to ovarian cancer chemotherapy. J Med Chem. 2018;61(19):8754–8773.
   PubMed Web of Science ®Google Scholar
• Rao Q-X, Yao T-T, Zhang B-Z, Lin R-C, Chen Z-L, Zhou H, Wang L-J, Lu H-W, Chen Q, Di N, et al. Expression and functional role of aldh1 in cervical carcinoma cells. Asian Pac J Cancer Prev. 2012;13(4):1325–1331.
   PubMedGoogle Scholar
• Yao T, Chen Q, Zhang B, Zhou H, Lin Z. The expression of aldh1 in cervical carcinoma. Med Sci Monit. 2011;17(8):HY21–26.
   PubMed Web of Science ®Google Scholar
• Jin N, Zhu X, Cheng F, Zhang L. Disulfiram/copper targets stem cell-like aldh(+) population of multiple myeloma by inhibition of aldh1a1 and hedgehog pathway. J Cell Biochem. 2018;119(8):6882–6893.
   PubMed Web of Science ®Google Scholar
• Levi BP, Yilmaz OH, Duester G, Morrison SJ. Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems. Blood. 2009;113(8):1670–1680.
   PubMed Web of Science ®Google Scholar
• Zhou L, Sheng D, Wang D, Ma W, Deng Q, Deng L, Liu S. Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (aldh) isoforms in aldefluor assay. Cell Biol Toxicol. 2019;35(2):161–177.
   PubMed Web of Science ®Google Scholar
• Morgan CA, Parajuli B, Buchman CD, Dria K, Hurley TD. N,n-diethylaminobenzaldehyde (deab) as a substrate and mechanism-based inhibitor for human aldh isoenzymes. Chem Biol Interact. 2015;234:18–28.
   PubMed Web of Science ®Google Scholar
• Chen Y, Orlicky DJ, Matsumoto A, Singh S, Thompson DC, Vasiliou V. Aldehyde dehydrogenase 1b1 (aldh1b1) is a potential biomarker for human colon cancer. Biochem Biophys Res Commun. 2011;405(2):173–179.
   PubMed Web of Science ®Google Scholar
• Marcato P, Dean CA, Giacomantonio CA, Lee PW. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle. 2011;10(9):1378–1384.
   PubMed Web of Science ®Google Scholar
• Yang X, Yao R, Wang H. Update of aldh as a potential biomarker and therapeutic target for aml. Biomed Res Int. 2018;2018:9192104.
   PubMed Web of Science ®Google Scholar
• Smith C, Gasparetto M, Humphries K, Pollyea DA, Vasiliou V, Jordan CT. Aldehyde dehydrogenases in acute myeloid leukemia. Ann NY Acad Sci. 2014;1310:58–68.
   PubMed Web of Science ®Google Scholar
• Gasparetto M, Sekulovic S, Brocker C, Tang P, Zakaryan A, Xiang P, Kuchenbauer F, Wen M, Kasaian K, Witty MF, et al. Aldehyde dehydrogenases are regulators of hematopoietic stem cell numbers and b-cell development. Exp Hematol. 2012;40(4):318–329 e312.
   PubMed Web of Science ®Google Scholar
• Singh S, Brocker C, Koppaka V, Chen Y, Jackson BC, Matsumoto A, Thompson DC, Vasiliou V. Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress. Free Radic Biol Med. 2013;56:89–101.
   PubMed Web of Science ®Google Scholar
• Gasparetto M, Smith CA. Aldhs in normal and malignant hematopoietic cells: potential new avenues for treatment of aml and other blood cancers. Chem Biol Interact. 2017;276:46–51.
   PubMed Web of Science ®Google Scholar
• Pearce DJ, Taussig D, Simpson C, Allen K, Rohatiner AZ, Lister TA, Bonnet D. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells. 2005;23(6):752–760.
   PubMed Web of Science ®Google Scholar
• Moreb JS, Turner C, Sreerama L, Zucali JR, Sladek NE, Schweder M. Interleukin-1 and tumor necrosis factor alpha induce class 1 aldehyde dehydrogenase mrna and protein in bone marrow cells. Leuk Lymphoma. 1995;20(1–2):77–84.
   PubMed Web of Science ®Google Scholar
• Moreb JS, Maccow C, Schweder M, Hecomovich J. Expression of antisense rna to aldehyde dehydrogenase class-1 sensitizes tumor cells to 4-hydroperoxycyclophosphamide in vitro. J Pharmacol Exp Ther. 2000;293(2):390–396.
   PubMed Web of Science ®Google Scholar
• Su M, Alonso S, Jones JW, Yu J, Kane MA, Jones RJ, Ghiaur G. All-trans retinoic acid activity in acute myeloid leukemia: role of cytochrome p450 enzyme expression by the microenvironment. PLoS One. 2015;10(6):e0127790.
   PubMed Web of Science ®Google Scholar
• Xu B, Wang S, Li R, Chen K, He L, Deng M, Kannappan V, Zha J, Dong H, Wang W. Disulfiram/copper selectively eradicates aml leukemia stem cells in vitro and in vivo by simultaneous induction of ros-jnk and inhibition of nf-kappab and nrf2. Cell Death Dis. 2017;8(5):e2797.
   PubMedGoogle Scholar
• Conticello C, Martinetti D, Adamo L, Buccheri S, Giuffrida R, Parrinello N, Lombardo L, Anastasi G, Amato G, Cavalli M, et al. Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies. Int J Cancer. 2012;131(9):2197–2203.
   PubMed Web of Science ®Google Scholar
• Bista R, Lee DW, Pepper OB, Azorsa DO, Arceci RJ, Aleem E. Disulfiram overcomes bortezomib and cytarabine resistance in down-syndrome-associated acute myeloid leukemia cells. J Exp Clin Cancer Res. 2017;36(1):22.
   PubMedGoogle Scholar
• Venton G, Perez-Alea M, Baier C, Fournet G, Quash G, Labiad Y, Martin G, Sanderson F, Poullin P, Suchon P, et al. Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors. Blood Cancer J. 2016;6(9):e469.
   PubMedGoogle Scholar
• Ratajczak J, Zuba-Surma E, Klich I, Liu R, Wysoczynski M, Greco N, Kucia M, Laughlin MJ, Ratajczak MZ. Hematopoietic differentiation of umbilical cord blood-derived very small embryonic/epiblast-like stem cells. Leukemia. 2011;25(8):1278–1285.
   PubMed Web of Science ®Google Scholar
• He X, Gonzalez V, Tsang A, Thompson J, Tsang TC, Harris DT. Differential gene expression profiling of cd34+ cd133+ umbilical cord blood hematopoietic stem progenitor cells. Stem Cells Dev. 2005;14(2):188–198.
   PubMed Web of Science ®Google Scholar
• Lassen N, Bateman JB, Estey T, Kuszak JR, Nees DW, Piatigorsky J, Duester G, Day BJ, Huang J, Hines LM, et al. Multiple and additive functions of aldh3a1 and aldh1a1: cataract phenotype and ocular oxidative damage in aldh3a1(–/–)/aldh1a1(–/–) knock-out mice. J Biol Chem. 2007;282(35):25668–25676.
   PubMed Web of Science ®Google Scholar
• Zhao D, Mo Y, Li MT, Zou SW, Cheng ZL, Sun YP, Xiong Y, Guan KL, Lei QY. Notch-induced aldehyde dehydrogenase 1a1 deacetylation promotes breast cancer stem cells. J Clin Invest. 2014;124(12):5453–5465.
   PubMed Web of Science ®Google Scholar
• Croker AK, Allan AL. Inhibition of aldehyde dehydrogenase (aldh) activity reduces chemotherapy and radiation resistance of stem-like aldhhicd44(+) human breast cancer cells. Breast Cancer Res Treat. 2012;133(1):75–87.
   PubMed Web of Science ®Google Scholar
• Yan Y, Li Z, Xu X, Chen C, Wei W, Fan M, Chen X, Li JJ, Wang Y, Huang J. All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy. BMC Complement Altern Med. 2016;16(113):113.
   PubMedGoogle Scholar
• Dehghan Harati M, Rodemann HP, Toulany M. Nanog signaling mediates radioresistance in aldh-positive breast cancer cells. Int J Mol Sci. 2019;20(5):1151.
   PubMed Web of Science ®Google Scholar
• Moreb JS, Ucar-Bilyeu DA, Khan A. Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells. Cancer Chemother Pharmacol. 2017;79(2):295–301.
   PubMed Web of Science ®Google Scholar
• Deng S, Yang X, Lassus H, Liang S, Kaur S, Ye Q, Li C, Wang LP, Roby KF, Orsulic S, et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (aldh1), in human epithelial cancers. PLoS One. 2010;5(4):e10277.
   PubMed Web of Science ®Google Scholar
• Rexer BN, Zheng WL, Ong DE. Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in mcf-7 cells. Cancer Res. 2001;61(19):7065–7070.
   PubMed Web of Science ®Google Scholar
• Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, et al. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform aldh1a3 and its expression is predictive of metastasis. Stem Cells. 2011;29(1):32–45.
   PubMed Web of Science ®Google Scholar
• Marcato P, Dean CA, Liu RZ, Coyle KM, Bydoun M, Wallace M, Clements D, Turner C, Mathenge EG, Gujar SA, et al. Aldehyde dehydrogenase 1a3 influences breast cancer progression via differential retinoic acid signaling. Mol Oncol. 2015;9(1):17–31.
   PubMed Web of Science ®Google Scholar
• Kato H, Izumi K, Saito T, Ohnuki H, Terada M, Kawano Y, Nozawa-Inoue K, Saito C, Maeda T. Distinct expression patterns and roles of aldehyde dehydrogenases in normal oral mucosa keratinocytes: differential inhibitory effects of a pharmacological inhibitor and RNAI-mediated knockdown on cellular phenotype and epithelial morphology. Histochem Cell Biol. 2013;139(6):847–862.
   PubMed Web of Science ®Google Scholar
• Hedberg JJ, Grafstrom RC, Vondracek M, Sarang Z, Warngard L, Hoog JO. Micro-array chip analysis of carbonyl-metabolising enzymes in normal, immortalised and malignant human oral keratinocytes. Cell Mol Life Sci. 2001;58(11):1719–1726.
   PubMed Web of Science ®Google Scholar
• Kahlert C, Bergmann F, Beck J, Welsch T, Mogler C, Herpel E, Dutta S, Niemietz T, Koch M, Weitz J. Low expression of aldehyde dehydrogenase 1a1 (aldh1a1) is a prognostic marker for poor survival in pancreatic cancer. BMC Cancer. 2011;11:275.
   PubMed Web of Science ®Google Scholar
• Kim IG, Lee JH, Kim SY, Kim JY, Cho EW. Fibulin-3 negatively regulates aldh1 via c-met suppression and increases gamma-radiation-induced sensitivity in some pancreatic cancer cell lines. Biochem Biophys Res Commun. 2014;454(3):369–375.
   PubMed Web of Science ®Google Scholar
• Moreb JS, Muhoczy D, Ostmark B, Zucali JR. Rnai-mediated knockdown of aldehyde dehydrogenase class-1a1 and class-3a1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide. Cancer Chemother Pharmacol. 2007;59(1):127–136.
   PubMed Web of Science ®Google Scholar
• Moreb JS, Gabr A, Vartikar GR, Gowda S, Zucali JR, Mohuczy D. Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde. J Pharmacol Exp Ther. 2005;312(1):339–345.
   PubMed Web of Science ®Google Scholar
• Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 2010;70(23):9937–9948.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lu C, Fang T, Wang Y, Hu W, Qiao J, Liu B, Liu J, Chen N, Li M, et al. Notch3 functions as a regulator of cell self-renewal by interacting with the beta-catenin pathway in hepatocellular carcinoma. Oncotarget. 2015;6(6):3669–3679.
   PubMedGoogle Scholar
• Xiao ZJ, Liu J, Wang SQ, Zhu Y, Gao XY, Tin VP, Qin J, Wang JW, Wong MP. Nfatc2 enhances tumor-initiating phenotypes through the nfatc2/sox2/aldh axis in lung adenocarcinoma. Elife. 2017;6:e26733.
   PubMed Web of Science ®Google Scholar
• Voronkova MA, Rojanasakul LW, Kiratipaiboon C, Rojanasakul Y. Sox9-aldh axis determines resistance to chemotherapy in non-small cell lung cancer. Mol Cell Biol. 2019;40(2):e00307-19.
   Web of Science ®Google Scholar
• Shao C, Sullivan JP, Girard L, Augustyn A, Yenerall P, Rodriguez-Canales J, Liu H, Behrens C, Shay JW, Wistuba II, et al. Essential role of aldehyde dehydrogenase 1a3 for the maintenance of non-small cell lung cancer stem cells is associated with the stat3 pathway. Clin Cancer Res. 2014;20(15):4154–4166.
   PubMed Web of Science ®Google Scholar
• Erfani E, Roudi R, Rakhshan A, Sabet MN, Shariftabrizi A, Madjd Z. Comparative expression analysis of putative cancer stem cell markers cd44 and aldh1a1 in various skin cancer subtypes. Int J Biol Markers. 2016;31(1):e53-61–e61.
   PubMed Web of Science ®Google Scholar
• Luo Y, Dallaglio K, Chen Y, Robinson WA, Robinson SE, McCarter MD, Wang J, Gonzalez R, Thompson DC, Norris DA, et al. Aldh1a isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells. 2012;30(10):2100–2113.
   PubMed Web of Science ®Google Scholar
• Vasiliou V, Thompson DC, Smith C, Fujita M, Chen Y. Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. Chem Biol Interact. 2013;202(1–3):2–10.
   PubMed Web of Science ®Google Scholar
• van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, Guzman-Ramirez N, Hamdy FC, Eaton CL, Thalmann GN, Cecchini MG, et al. High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res. 2010;70(12):5163–5173.
   PubMed Web of Science ®Google Scholar
• Kalantari E, Saadi FH, Asgari M, Shariftabrizi A, Roudi R, Madjd Z. Increased expression of aldh1a1 in prostate cancer is correlated with tumor aggressiveness: a tissue microarray study of Iranian patients. Appl Immunohistochem Mol Morphol. 2017;25(8):592–598.
   PubMedGoogle Scholar
• Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, Wicha MS, Prince ME. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck. 2010;32(9):1195–1201.
   PubMed Web of Science ®Google Scholar
• Wu J, Mu Q, Thiviyanathan V, Annapragada A, Vigneswaran N. Cancer stem cells are enriched in fanconi anemia head and neck squamous cell carcinomas. Int J Oncol. 2014;45(6):2365–2372.
   PubMed Web of Science ®Google Scholar
• Kurth I, Hein L, Mabert K, Peitzsch C, Koi L, Cojoc M, Kunz-Schughart L, Baumann M, Dubrovska A. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma. Oncotarget. 2015;6(33):34494–34509.
   PubMedGoogle Scholar
• Suzuki E, Chiba T, Zen Y, Miyagi S, Tada M, Kanai F, Imazeki F, Miyazaki M, Iwama A, Yokosuka O. Aldehyde dehydrogenase 1 is associated with recurrence-free survival but not stem cell-like properties in hepatocellular carcinoma. Hepatol Res. 2012;42(11):1100–1111.
   PubMed Web of Science ®Google Scholar
• Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene. 2011;30(31):3454–3467.
   PubMed Web of Science ®Google Scholar
• Xu SL, Liu S, Cui W, Shi Y, Liu Q, Duan JJ, Yu SC, Zhang X, Cui YH, Kung HF, et al. Aldehyde dehydrogenase 1a1 circumscribes high invasive glioma cells and predicts poor prognosis. Am J Cancer Res. 2015;5(4):1471–1483.
   PubMed Web of Science ®Google Scholar
• Mao P, Joshi K, Li J, Kim SH, Li P, Santana-Santos L, Luthra S, Chandran UR, Benos PV, Smith L, et al. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1a3. Proc Natl Acad Sci USA. 2013;110(21):8644–8649.
   PubMed Web of Science ®Google Scholar
• Unguryte A, Bernotiene E, Bagdonas E, Garberyte S, Porvaneckas N, Jorgensen C. Human articular chondrocytes with higher aldehyde dehydrogenase activity have stronger expression of col2a1 and sox9. Osteoarthritis Cartilage. 2016;24(5):873–882.
   PubMed Web of Science ®Google Scholar
• Russo JE, Hauguitz D, Hilton J. Inhibition of mouse cytosolic aldehyde dehydrogenase by 4-(diethylamino)benzaldehyde. Biochem Pharmacol. 1988;37(8):1639–1642.
   PubMed Web of Science ®Google Scholar
• Wang MF, Han CL, Yin SJ. Substrate specificity of human and yeast aldehyde dehydrogenases. Chem Biol Interact. 2009;178(1–3):36–39.
   PubMed Web of Science ®Google Scholar
• Koppaka V, Thompson DC, Chen Y, Ellermann M, Nicolaou KC, Juvonen RO, Petersen D, Deitrich RA, Hurley TD, Vasiliou V. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol Rev. 2012;64(3):520–539.
   PubMed Web of Science ®Google Scholar
• Pors K, Moreb JS. Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development? Drug Discov Today. 2014;19(12):1953–1963.
   PubMedGoogle Scholar
• Russo JE, Hilton J. Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant l1210 cells. Cancer Res. 1988;48(11):2963–2968.
   PubMed Web of Science ®Google Scholar
• Ali IM, Ibrahim EB, Sneha S, Jiménez R, Pequerul R, Parés X, Rüngeler T, Jha V, Tuccinardi T, Sadiq M, et al. Klaus Pors Expansion of the 4-(diethylamino)benzaldehyde scaffold to explore the impact on aldehyde dehydrogenase activity and antiproliferative activity in prostate cancer. J Med Chem. 2022;65(5):16.
   Web of Science ®Google Scholar
• Yao L, Fan P, Arolfo M, Jiang Z, Olive MF, Zablocki J, Sun HL, Chu N, Lee J, Kim HY, et al. Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating thp, a cocaine use-dependent inhibitor of dopamine synthesis. Nat Med. 2010;16(9):1024–1028.
   PubMed Web of Science ®Google Scholar
• Lai CL, Li YP, Liu CM, Hsieh HS, Yin SJ. Inhibition of human alcohol and aldehyde dehydrogenases by cimetidine and assessment of its effects on ethanol metabolism. Chem Biol Interact. 2013;202(1–3):275–282.
   PubMed Web of Science ®Google Scholar
• Jianfeng Li SG, Ye Z, Moretti A, Belyaeva OV, Beiser A, Ibrahim M, Wilk A, McClellan S, Klyuyeva AV, Goggans KR, et al. A specific inhibitor of aldh1a3 regulates retinoic acid biosynthesis in glioma stem cells. Commun Biol. 2021;4(1):1420.
   PubMed Web of Science ®Google Scholar
• Kumar LLS, Trainor PA, Koentgen F, Duester G. Alcohol and aldehyde dehydrogenases: retinoid metabolic effects in mouse knockout models. Biochim Biophys Acta. 2012;1821(1):8.
   Web of Science ®Google Scholar
• Karen Niederreither VF, Garnier J-M, Chambon P, Dollé P. Differential expression of retinoic acid-synthesizing (raldh) enzymes during fetal development and organ differentiation in the mouse. Mech Dev. 2002;110(1–2):5.
   Web of Science ®Google Scholar
• Bingyan Li Kang Yang DL, Jiang C, Ma Z. Discovery and development of selective aldehyde dehydrogenase 1a1 (aldh1a1) inhibitors. Eur J Med Chem. 2021;2021:209.
   Google Scholar
• Gelardi ELM, Colombo G, Picarazzi F, Ferraris DM, Mangione A, Petrarolo G, Aronica E, Rizzi M, Mori M, La Motta C, et al. A selective competitive inhibitor of aldehyde dehydrogenase 1a3 hinders cancer cell growth, invasiveness and stemness in vitro. Cancers . 2021;2021(2):13.
   Google Scholar
• Liu ZJ, Sun YJ, Rose J, Chung YJ, Hsiao CD, Chang WR, Kuo I, Perozich J, Lindahl R, Hempel J, et al. The first structure of an aldehyde dehydrogenase reveals novel interactions between nad and the rossmann fold. Nat Struct Biol. 1997;4(4):317–326.
   PubMedGoogle Scholar
• Feng Z, Hom ME, Bearrood TE, Rosenthal ZC, Fernandez D, Ondrus AE, Gu Y, McCormick AK, Tomaske MG, Marshall CR, et al. Targeting colorectal cancer with small-molecule inhibitors of aldh1b1. Nat Chem Biol. 2022;18(10):1065–1075.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang T, Korkaya H, Liu S, Lee HF, Newman B, Yu Y, Clouthier SG, Schwartz SJ, Wicha MS, et al. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res. 2010;16(9):2580–2590.
   PubMed Web of Science ®Google Scholar
• Morgan CA, Hurley TD. Development of a high-throughput in vitro assay to identify selective inhibitors for human aldh1a1. Chem Biol Interact. 2015;234:29–37.
   PubMed Web of Science ®Google Scholar
• Moretti A, Li J, Donini S, Sobol RW, Rizzi M, Garavaglia S. Crystal structure of human aldehyde dehydrogenase 1a3 complexed with nad(+) and retinoic acid. Sci Rep. 2016;6:35710.
   PubMed Web of Science ®Google Scholar
• Condello S, Morgan CA, Nagdas S, Cao L, Turek J, Hurley TD, Matei D. Beta-catenin-regulated aldh1a1 is a target in ovarian cancer spheroids. Oncogene. 2015;34(18):2297–2308.
   PubMed Web of Science ®Google Scholar
• Parajuli B, Kimble-Hill AC, Khanna M, Ivanova Y, Meroueh S, Hurley TD. Discovery of novel regulators of aldehyde dehydrogenase isoenzymes. Chem Biol Interact. 2011;191(1–3):153–158.
   PubMed Web of Science ®Google Scholar
• Ibrahim AIM, Ikhmais B, Batlle E, AbuHarb WK, Jha V, Jaradat KT, Jimenez R, Pequerul R, Pares X, Farres J, et al. Design, synthesis, biological evaluation and in silico study of benzyloxybenzaldehyde derivatives as selective aldh1a3 inhibitors. Molecules. 2021;26(19):5770.
   PubMed Web of Science ®Google Scholar
• King G, Hirst L, Holmes R. Human corneal and lens aldehyde dehydrogenases. Localization and function(s) of ocular aldh1 and aldh3 isozymes. Adv Exp Med Biol. 1999;463:189–198.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Sperkova Z, Napoli JL. Cellular expression of retinal dehydrogenase types 1 and 2: effects of vitamin a status on testis MRNA. J Cell Physiol. 2001;186(2):220–232.
   PubMed Web of Science ®Google Scholar
• Armstrong L, Stojkovic M, Dimmick I, Ahmad S, Stojkovic P, Hole N, Lako M. Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells. 2004;22(7):1142–1151.
   PubMed Web of Science ®Google Scholar
• Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ, McDonnell DP. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci USA. 2006;103(31):11707–11712.
   PubMed Web of Science ®Google Scholar
• Hsu LC, Chang WC, Hiraoka L, Hsieh CL. Molecular cloning, genomic organization, and chromosomal localization of an additional human aldehyde dehydrogenase gene, aldh6. Genomics. 1994;24(2):333–341.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang QY, Liu D, Su T, Weng Y, Ling G, Chen Y, Gu J, Schilling B, Ding X. Expression of cytochrome p450 and other biotransformation genes in fetal and adult human nasal mucosa. Drug Metab Dispos. 2005;33(10):1423–1428.
   PubMed Web of Science ®Google Scholar
• Marchitti SA, Orlicky DJ, Brocker C, Vasiliou V. Aldehyde dehydrogenase 3b1 (aldh3b1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues. J Histochem Cytochem. 2010;58(9):765–783.
   PubMed Web of Science ®Google Scholar
• Singh S, Arcaroli J, Thompson DC, Messersmith W, Vasiliou V. Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers. Adv Exp Med Biol. 2015;815:281–294.
   PubMed Web of Science ®Google Scholar
• Cheung AM, Wan TS, Leung JC, Chan LY, Huang H, Kwong YL, Liang R, Leung AY. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior nod/scid engrafting potential. Leukemia. 2007;21(7):1423–1430.
   PubMed Web of Science ®Google Scholar
• Liu C, Qiang J, Deng Q, Xia J, Deng L, Zhou L, Wang D, He X, Liu Y, Zhao B, et al. Aldh1a1 activity in tumor-initiating cells remodels myeloid-derived suppressor cells to promote breast cancer progression. Cancer Res. 2021;81(23):5919–5934.
   PubMed Web of Science ®Google Scholar
• Ciccone V, Terzuoli E, Ristori E, Filippelli A, Ziche M, Morbidelli L, Donnini S. ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL-8/Notch signaling cascade. Int J Mol Med. 2022;50(1):5155.
   Web of Science ®Google Scholar
• Choi SA, Lee JY, Phi JH, Wang KC, Park CK, Park SH, Kim SK. Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase. Eur J Cancer. 2014;50(1):137–149.
   PubMed Web of Science ®Google Scholar
• Wang Y, Shao F, Chen L. L C. Aldh1a2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating stat3. Onco Targets Ther. 2018;11:599–608.
   PubMed Web of Science ®Google Scholar
• Nie S, Qian X, Shi M, Li H, Peng C, Ding X, Zhang S, Zhang B, Xu G, Lv Y, et al. Aldh1a3 accelerates pancreatic cancer metastasis by promoting glucose metabolism. Front Oncol. 2020;10:915.
   PubMed Web of Science ®Google Scholar
• Duan JJ, Wang D, Cai J, Chen JJ, Zheng XX, Chen TQ, Wang J, Zhang X, Yang QK, Yu SC. An aldehyde dehydrogenase 1a3 inhibitor attenuates the metastasis of human colorectal cancer. Cancer Lett. 2022;536:215662.
   PubMed Web of Science ®Google Scholar
• Crunkhorn S. Targeting aldh1b1 in colorectal cancer. Nat Rev Drug Discov. 2022;21(9):636.
   Web of Science ®Google Scholar
• Wang Y, Li K, Zhao W, Liu Z, Liu J, Shi A, Chen T, Mu W, Xu Y, Pan C, et al. Aldehyde dehydrogenase 3b2 promotes the proliferation and invasion of cholangiocarcinoma by increasing integrin beta 1 expression. Cell Death Dis. 2021;12(12):1158.
   PubMed Web of Science ®Google Scholar
• Guo YF, Duan JJ, Wang J, Li L, Wang D, Liu XZ, Yang J, Zhang HR, Lv J, Yang YJ, et al. Inhibition of the aldh18a1-mycn positive feedback loop attenuates mycn-amplified neuroblastoma growth. Sci Transl Med. 2020;12:531.
   Web of Science ®Google Scholar
• Canuto RA, Muzio G, Salvo RA, Maggiora M, Trombetta A, Chantepie J, Fournet G, Reichert U, Quash G. The effect of a novel irreversible inhibitor of aldehyde dehydrogenases 1 and 3 on tumour cell growth and death. Chem Biol Interact. 2001;130–132(1–3):209–218.
   PubMed Web of Science ®Google Scholar